Speaker Profile
Ph.D., CEO, Numenos
Biography
Vitalay Fomin is the CEO and co-founder of Numenos with the purpose to develop novel AI approaches in clinical drug development . Vitalay is a data scientist and molecular biologist combining data science and experimental biology to reveal and target novel mechanisms contributing to disease progression and drug response. At Roche/Genentech, he developed innovative workflows to identify genomic and biomarker features affecting immunotherapy response, particularly in non-small cell lung carcinoma (NSCLC). His research leveraged large clinico-genomic databases (Flatiron Health), vast internal clinical trial data and cutting-edge machine learning approaches to understand checkpoint inhibitor resistance in cancer. Our goal os to create novel AI infrastructure to convert vast amounts of uninterpretable human data into real world applications using novel implementations of AI by generating a large clinic-genomic model (LCGM), that can semantically harmonize biological data to come up with for foundational biological concepts, the equivalent of the physics laws for biology.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures & Gad Getz, Broad Institute
PMWC Award Ceremony
• David Baker, University of Washington (Nobel Laureate, Luminary)
Featured Speakers
• David Baker, University of Washington
• Jack Dent, Chai Discovery
• Dimitri Yatsenko, DataJoint
• Evgeny Kiner, Neosplice Therapeutics
• Alex Morgan, Khosla Ventures
• Gad Getz, Broad Institute
Causal Targets, Not Just Better Molecules
Using AI and human biology to improve target selection before chemistry begins.
Data Is the Moat
What proprietary, longitudinal, and perturbational data really confer advantage.
From Prediction to Patient
Patient stratification, smarter trials, and the handoff from model to clinic.
Designed Biology Meets Drug Development
AI-designed proteins, developability, and what survives contact with reality.
The Target Discovery Bottleneck
Why splicing and other underused biology may expand what is druggable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
